Assessment of CD19 exon 2 abundance as a proxy for CD19delta expression and prediction of anti-CD19 CAR therapy relapse

Søren Helweg Dam, Mike Bogetofte Barnkob, Kristoffer Vitting-Seerup

Research output: Contribution to conference › Poster › Research › peer-review

61 Downloads (Pure)

Original language	English
Publication date	2022
Publication status	Published - 2022
Event	10th Annual Immuno-Oncology Summit - Boston, United States Duration: 12 Oct 2022 → 14 Oct 2022 Conference number: 10

Conference	10th Annual Immuno-Oncology Summit
Number	10
Country/Territory	United States
City	Boston
Period	12/10/2022 → 14/10/2022

Access to Document

@conference{e65fe9e117e940238e6822be9e71d444,

title = "Assessment of CD19 exon 2 abundance as a proxy for CD19delta expression and prediction of anti-CD19 CAR therapy relapse",

author = "Dam, {S{\o}ren Helweg} and {Bogetofte Barnkob}, Mike and Kristoffer Vitting-Seerup",

year = "2022",

language = "English",

note = "10th Annual Immuno-Oncology Summit ; Conference date: 12-10-2022 Through 14-10-2022",

}

Assessment of CD19 exon 2 abundance as a proxy for CD19delta expression and prediction of anti-CD19 CAR therapy relapse. / Dam, Søren Helweg; Bogetofte Barnkob, Mike; Vitting-Seerup, Kristoffer.
2022. Poster session presented at 10th Annual Immuno-Oncology Summit, Boston, Massachusetts, United States.

Research output: Contribution to conference › Poster › Research › peer-review